Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.32%
SPX
-0.01%
IXIC
+0.05%
FTSE
+0.22%
N225
-0.21%
AXJO
+1.37%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

About

What does ALKS do?
Alkermes Plc is a biopharmaceutical company based in Dublin, focused on developing treatments for alcohol and opioid dependence, schizophrenia, and bipolar I disorder, employing 2,100 people. Its key products include LYBALVI, ARISTADA, and VIVITROL, with ongoing development for neurological disorders and cancer.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Ireland
Website
http://www.alkermes.com

Key Stats

Market Cap
4.75B
Dividend Yield
0.00%
P/E Ratio
13.47
EPS
2.23
Revenue
1.56B
Avg. Volume
2.44M

Recently from Cashu

publisher logo
Cashu

Alkermes plc: Diverse Analyst Perspectives on Growth and Challenges in Neuropsych Development

3 days ago
publisher logo
Cashu

Alkermes plc: Mixed Analyst Views on Biotech Potential and Market Challenges

5 days ago
publisher logo
Cashu

Alkermes plc: Analysts’ Mixed Views on Future Prospects in a Complex Pharma Landscape

about 1 month ago
Stocks
Health Care
alks
Alkermes plc
ALKS
-0.14 (-0.49%)
29.215
USD
At close at Jul 18, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials